FDA inspection
Hackensack Meridian Health IRB: FDA inspection ending Nov 24, 2025
FDA inspection 1293604 · Nutley, NJ
Key facts
| Inspection ID | 1293604 |
|---|---|
| Firm | Hackensack Meridian Health IRB |
| FEI number | 2243262 |
| Address | 123 Metro Blvd Ste 6100 |
| City | Nutley |
| State | NJ |
| ZIP | 07110-6101 |
| Fiscal year | 2026 |
| Inspection end date | Nov 24, 2025 |
| Project area | Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices |
| Product type | Biologics, Devices, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data